Assembly Biosciences Inc
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | -3,592.2% | – | – | – | – | – | -324.8% | – | |
| – | +492.2% | +23.5% | +173.2% | +193.3% | -23.2% | +39.9% | -32.6% | +6.9% | -9.6% | -71.3% | +0.0% | |
| – | -30.4% | -36.2% | +71.2% | +231.2% | -27.8% | +6.3% | -76.0% | +25.9% | -22.4% | -39.1% | +49.9% | |
| – | -30.2% | -29.8% | -97.0% | +17,687.3% | -17.7% | +18.5% | +64.4% | -78.7% | – | – | – | |
| – | – | +110.0% | +1,080.0% | -109.5% | – | – | – | – | – | -115.7% | – | |
| – | -61.1% | +151.2% | +490.8% | -60.7% | +357.1% | +42.9% | +39.5% | -96.7% | +150.0% | -89.0% | +135.7% | |
| – | -23,479.7% | – | -143.2% | +765.6% | -62.8% | – | -61.0% | +241.8% | -176.3% | – | -382.5% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +387.7% | -99.8% | +43,951.7% | +137.6% | -12.6% | -94.6% | – | – | – | – | – | |
| – | +387.7% | -99.8% | +43,951.7% | +137.6% | -12.6% | -94.6% | +598.3% | -98.8% | +2,150.5% | +113.1% | +493.1% | |
| – | -197.7% | – | +3,542.7% | -175.9% | – | +141.6% | -208.7% | – | -579.7% | – | +8.7% | |
| – | – | – | – | -6,659.2% | – | – | – | – | – | -327.4% | – |
Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.